Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Goldman Sachs is optimistic about A shares, but has downgraded H shares to benchmark: when the Japanese and Korean markets are stronger, the cost of waiting for H shares to recover increases.
OpenAI has released six financial and legal plugins hard competing with Anthropic enterprise clients, rekindling the battle.
The Yen is approaching the 160 red line, Komayama Kozuki issues another warning! Rate hike may be the last "life-saving straw" The Bank of Japan has been pushed into a corner.
Goldman Sachs is optimistic about A shares, but has downgraded H shares to benchmark: when the Japanese and Korean markets are stronger, the cost of waiting for H shares to recover increases.
OpenAI has released six financial and legal plugins hard competing with Anthropic enterprise clients, rekindling the battle.
The Yen is approaching the 160 red line, Komayama Kozuki issues another warning! Rate hike may be the last "life-saving straw" The Bank of Japan has been pushed into a corner.
